Status:
COMPLETED
Effect of Insulin Resistance Reducing Agents Pre and Post CABG on Post-operative Metabolic Status and Oxidative Stress
Lead Sponsor:
Mohammad Hassan Eftekhari
Collaborating Sponsors:
Shiraz University of Medical Sciences
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
30-70 years
Phase:
PHASE2
Brief Summary
The present study aimed to evaluate the effect of a combination of insulin resistance reducing agents pre and post coronary artery bypass grafting surgery on post-operative blood glucose and oxidative...
Detailed Description
The present study aimed to evaluate the effect of a combination of insulin resistance reducing agents pre and post coronary artery bypass grafting surgery on post-operative blood glucose and oxidative...
Eligibility Criteria
Inclusion
- Mean age of 30-70 years old, Having Coronary Artery Disease
- Undergoing coronary artery bypass grafting surgery
Exclusion
- Positive history of diabetes mellitus, metabolic, hematological, and immune disorders, renal problem, and cerebrovascular accident
- Taking antioxidant supplements
- Cases for emergency operations
- Ejection Fraction \< 30%
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT02184507
Start Date
June 1 2013
End Date
July 1 2014
Last Update
October 24 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.